Corrigendum to "Antiliver Fibrosis Screening of Active Ingredients from <i>Apium graveolens</i> L. Seeds via GC-TOF-MS and UHPLC-MS/MS".

Qiao, Ming; Yang, Jianhua; Zhao, Yao; Zhu, Yi; Wang, Xiaomei; Wang, Xinling; Hu, Junping

Corrigendum to "Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS".

Qiao, Ming; Yang, Jianhua; Zhao, Yao; Zhu, Yi; Wang, Xiaomei; Wang, Xinling; Hu, Junping.

Afiliación

Qiao M; College of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.
Yang J; Department of Pharmacy, The First Affiliated Hospital, Xinjiang Medical University, Urumqi 830011, China.
Zhao Y; College of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.
Zhu Y; Department of Pharmacy, The First Affiliated Hospital, Xinjiang Medical University, Urumqi 830011, China.
Wang X; College of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.
Wang X; College of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.
Hu J; College of Pharmacy, Xinjiang Medical University, Urumqi 830011, China.

Evid Based Complement Alternat Med ; 2022: 9818920, 2022.

Article en En | MEDLINE | ID: mdl-35535152

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: Evid Based Complement Alternat Med Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google